Vena Cava Clips and Filters

Vena Cava Clips and Filters

Global Vena Cava Clips and Filters Market to Reach US$2.5 Billion by 2030

The global market for Vena Cava Clips and Filters estimated at US$1.3 Billion in the year 2023, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 9.7% over the analysis period 2023-2030. Inferior Vena Cava Clips and Filters, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Superior Vena Cava Clips and Filters segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$349.1 Million While China is Forecast to Grow at 16.6% CAGR

The Vena Cava Clips and Filters market in the U.S. is estimated at US$349.1 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$632.5 Million by the year 2030 trailing a CAGR of 16.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 8.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Vena Cava Clips and Filters - Key Trends and Drivers

The vena cava clips and filters (IVCF) market is experiencing significant growth due to advancements in medical device technology that have enhanced the utilization and procedural success of IVCFs. These devices are critical in preventing pulmonary embolism by capturing blood clots before they can reach the lungs. Recent technical improvements, such as the introduction of curved inner sheaths, have enhanced the directionality and success of snaring IVCF hooks that deviate from the central axis, facilitating easier placement and retrieval. Innovations like laser photoablation and the use of endobronchial forceps for removing permanent filters have further simplified these procedures, making them accessible to practitioners without extensive surgical skills. This reduction in procedural complexity and risk is anticipated to drive a steady increase in the adoption of vena cava clips and filters, contributing to market growth during the forecast period.

The vena cava clips and filters market is also bolstered by increased research and development (R&D) efforts leading to the launch of technologically advanced vena cava filters (VCFs). These advancements have produced smaller, more easily insertable filters that can be positioned percutaneously and even bedside, making them more versatile and less invasive. Features such as MRI compatibility and adaptability to various vena cava diameters have broadened the potential use cases for VCFs. Additionally, there is a growing emphasis on developing drug-eluting filters that can prevent complications like intimal hyperplasia and thrombus formation. These innovations are expected to propel the global vena cava clips and filters market to expand at a compound annual growth rate (CAGR) of more than 11% from 2019 to 2023.

Leading the innovation and market expansion are key manufacturers such as Cook Medical, B. Braun Melsungen AG, Cardinal Health, Boston Scientific Corporation, and Becton, Dickinson and Co, among others. These companies are at the forefront of the vena cava clips and filters market, driving development and availability of next-generation VCFs globally. Other notable players include Shandong Weigao Group Medical Polymer Co. Ltd, Argon Medical Devices, and C.R. Bard, Inc., each contributing to the competitive landscape and technological advancement within the sector. Their collective efforts in R&D and product innovation are crucial in meeting the evolving needs of the healthcare industry, ensuring ongoing growth and improvement in patient care through enhanced vena cava filter solutions.

Select Competitors (Total 86 Featured) -

• ALN Implants chirurgicaux
• Argon Medical Devices Inc.
• B. Braun SE
• Becton, Dickinson and Co.
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cook Group Inc.
• Hotze Runkle PLLC
• Integer Holdings Corporation
• Kossel Medtech (Suzhou) Co., Ltd
• LifeTech Scientific Corporation
• Merit Medical Systems, Inc.
• Mermaid Medical A/S;

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.